Cytokinetics (CYTK) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Cytokinetics (CYTK) over the last 15 years, with Q3 2024 value amounting to -$2.6 billion.
- Cytokinetics' Retained Earnings fell 3000.0% to -$2.6 billion in Q3 2024 from the same period last year, while for Sep 2024 it was -$2.6 billion, marking a year-over-year decrease of 3000.0%. This contributed to the annual value of -$2.1 billion for FY2023, which is 3318.07% down from last year.
- According to the latest figures from Q3 2024, Cytokinetics' Retained Earnings is -$2.6 billion, which was down 3000.0% from -$2.4 billion recorded in Q2 2024.
- In the past 5 years, Cytokinetics' Retained Earnings registered a high of -$904.4 million during Q1 2020, and its lowest value of -$2.6 billion during Q3 2024.
- For the 5-year period, Cytokinetics' Retained Earnings averaged around -$1.5 billion, with its median value being -$1.3 billion (2022).
- In the last 5 years, Cytokinetics' Retained Earnings plummeted by 1366.58% in 2020 and then tumbled by 4130.86% in 2023.
- Quarter analysis of 5 years shows Cytokinetics' Retained Earnings stood at -$992.3 million in 2020, then dropped by 21.7% to -$1.2 billion in 2021, then plummeted by 31.33% to -$1.6 billion in 2022, then tumbled by 33.18% to -$2.1 billion in 2023, then dropped by 23.09% to -$2.6 billion in 2024.
- Its Retained Earnings was -$2.6 billion in Q3 2024, compared to -$2.4 billion in Q2 2024 and -$2.2 billion in Q1 2024.